Physicians have been prescribing Merck’s COVID-19 antiviral at higher-than-expected rates amid shortages of Pfizer’s antiviral Paxlovid, The Wall Street Journal reported March 14.
Read the full post on Becker's Hospital Review - Healthcare News
Merck antiviral used more than expected, data shows
